Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
We received an updated WNV package insert; please note the manufacturer and license number has been ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...